04 Trial In Patients With Metastatic Soft Tissue Sarcoma (Sts)

Lytix Biopharma AS

05/06/2022 14:31

June 5 (Reuters) - Lytix Biopharma AS  LYTIX.OL :
    * ANNOUNCES DATA FROM ITS ATLAS-IT-04 TRIAL IN PATIENTS WITH
METASTATIC SOFT TISSUE SARCOMA (STS)
    * LYTIX BIOPHARMA-  LTX-315 IN COMBINATION WITH ADOPTIVE
CELL
THERAPY WAS ABLE TO STABILIZE DISEASE IN 3 OUT OF 4 FULLY
TREATED PATIENTS
    * LTX-315 TREATMENT GENERATED TUMOR-SPECIFIC T CELLS

Source text for Eikon:  ID:nObifTKZxa 
Further company coverage:  LYTIX.OL 

 ((Reuters.Briefs@thomsonreuters.com;))